We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Intarcia Announces Acquisition of Phoundry Pharmaceuticals

News   Sep 28, 2015

 
Intarcia Announces Acquisition of Phoundry Pharmaceuticals
 
 
 

RELATED ARTICLES

HIV Suppressed for up to Four Months by Novel Antibody

News

Regular infusions of an antibody that blocks the HIV binding site on human immune cells may have suppressed levels of HIV for up to four months.

READ MORE

Pneumococcal Vaccine Has Big Impact Even for the Unvaccinated

News

A vaccine against Streptococcus pneumoniae, a major cause of childhood illness and mortality in the developing world, sharply reduced the incidence of serious pneumococcal disease among children in a large Kenyan community.

READ MORE

Arsenic Harnessed to Create Broad-Spectrum Antibiotic

News

Although it contains arsenic, researchers say they tested the antibiotic's toxicity on human blood cells and reported that “it doesn’t kill human cells in tissue culture.”

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE